By tf-lawyer.com On October 17, the National Health Commission of China announced the release of the “Guidelines for the Diagnosis and Treatment of Obesity (2024 Edition)” aimed at enhancing the standardization of obesity treatment and ensuring the safety and quality of medical care for patients.
In recent years, the prevalence of overweight and obesity in China has been on the rise. As a distinct chronic disease and a significant contributing factor to various other chronic conditions, obesity has become a major public health issue in the country, ranking as the sixth leading cause of death and disability. The guidelines emphasize the effectiveness of a multidisciplinary collaborative approach to improve the standard of care in obesity treatment.
The main goal of these guidelines is to standardize obesity clinical practices across the nation, provide personalized treatment plans for patients, and continuously enhance the consistency of obesity treatment in medical institutions. This effort aims to improve treatment outcomes and long-term health prognosis for individuals struggling with obesity.
For further details, the full text of the “Guidelines for the Diagnosis and Treatment of Obesity (2024 Edition)” is available.
